abstract |
(57) [Summary] [Object] To provide a novel β3 adrenergic receptor agonist useful for the treatment of diabetes, obesity and gastrointestinal disorders. [Structure] General formula (I): Or a pharmacologically acceptable salt thereof; And a therapeutic agent for diabetes, obesity and gastrointestinal diseases containing the compound. |